BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25289758)

  • 1. A pattern of early radiation-induced inflammatory cytokine expression is associated with lung toxicity in patients with non-small cell lung cancer.
    Siva S; MacManus M; Kron T; Best N; Smith J; Lobachevsky P; Ball D; Martin O
    PLoS One; 2014; 9(10):e109560. PubMed ID: 25289758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic body radiation therapy and intensity modulated radiation therapy induce different plasmatic cytokine changes in non-small cell lung cancer patients: a pilot study.
    Trovo M; Giaj-Levra N; Furlan C; Bortolin MT; Muraro E; Polesel J; Minatel E; Tedeschi R; Filippi AR; Alongi F; Ricardi U
    Clin Transl Oncol; 2016 Oct; 18(10):1003-10. PubMed ID: 26687367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03.
    Hartsell WF; Scott CB; Dundas GS; Mohiuddin M; Meredith RF; Rubin P; Weigensberg IJ
    Am J Clin Oncol; 2007 Aug; 30(4):368-76. PubMed ID: 17762437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model combining age, equivalent uniform dose and IL-8 may predict radiation esophagitis in patients with non-small cell lung cancer.
    Wang S; Campbell J; Stenmark MH; Stanton P; Zhao J; Matuszak MM; Ten Haken RK; Kong FM
    Radiother Oncol; 2018 Mar; 126(3):506-510. PubMed ID: 29496281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining physical and biologic parameters to predict radiation-induced lung toxicity in patients with non-small-cell lung cancer treated with definitive radiation therapy.
    Stenmark MH; Cai XW; Shedden K; Hayman JA; Yuan S; Ritter T; Ten Haken RK; Lawrence TS; Kong FM
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e217-22. PubMed ID: 22935395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
    Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine plasma levels: reliable predictors for radiation pneumonitis?
    Rübe CE; Palm J; Erren M; Fleckenstein J; König J; Remberger K; Rübe C
    PLoS One; 2008 Aug; 3(8):e2898. PubMed ID: 18682839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and Michigan.
    Zhao L; Wang L; Ji W; Wang X; Zhu X; Hayman JA; Kalemkerian GP; Yang W; Brenner D; Lawrence TS; Kong FM
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1385-90. PubMed ID: 19231104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung.
    Byhardt RW; Scott C; Sause WT; Emami B; Komaki R; Fisher B; Lee JS; Lawton C
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):469-78. PubMed ID: 9806503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.
    Bahri S; Flickinger JC; Kalend AM; Deutsch M; Belani CP; Sciurba FC; Luketich JD; Greenberger JS
    Radiat Oncol Investig; 1999; 7(5):297-308. PubMed ID: 10580899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.
    Singh AK; Lockett MA; Bradley JD
    Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):337-41. PubMed ID: 12527046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy or chemotherapy followed by radiotherapy with or without amifostine in locally advanced lung cancer.
    Antonadou D
    Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):50-8. PubMed ID: 11917285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Levels of IL-8 and TGF-β1 Predict Radiation-Induced Lung Toxicity in Non-Small Cell Lung Cancer: A Validation Study.
    Wang S; Campbell J; Stenmark MH; Zhao J; Stanton P; Matuszak MM; Ten Haken RK; Kong FS
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):615-621. PubMed ID: 28581403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine and soluble programmed death-ligand 1 levels in serum and plasma of cancer patients treated with immunotherapy: Preanalytical and analytical considerations.
    Cappelletto E; Fasiolo LT; Salizzato V; Piccin L; Fabozzi A; Contato A; Bianco PD; Pasello G; Chiarion-Sileni V; Gion M; Fabricio ASC
    Int J Biol Markers; 2024 Mar; 39(1):9-22. PubMed ID: 38407953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline plasma proteomic analysis to identify biomarkers that predict radiation-induced lung toxicity in patients receiving radiation for non-small cell lung cancer.
    Cai XW; Shedden KA; Yuan SH; Davis MA; Xu LY; Xie CY; Fu XL; Lawrence TS; Lubman DM; Kong FM
    J Thorac Oncol; 2011 Jun; 6(6):1073-8. PubMed ID: 21532507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-Institutional Prospective Study of Reirradiation with Proton Beam Radiotherapy for Locoregionally Recurrent Non-Small Cell Lung Cancer.
    Chao HH; Berman AT; Simone CB; Ciunci C; Gabriel P; Lin H; Both S; Langer C; Lelionis K; Rengan R; Hahn SM; Prabhu K; Fagundes M; Hartsell W; Mick R; Plastaras JP
    J Thorac Oncol; 2017 Feb; 12(2):281-292. PubMed ID: 27826034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and dosimetric predictors of radiation-induced esophageal toxicity.
    Maguire PD; Sibley GS; Zhou SM; Jamieson TA; Light KL; Antoine PA; Herndon JE; Anscher MS; Marks LB
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):97-103. PubMed ID: 10477012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in lung and breast cancer are altered during chest radiotherapy.
    Susskind H; Hymowitz MH; Lau YH; Atkins HL; Hurewitz AN; Valentine ES; Meek AG; Zucker S
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1161-9. PubMed ID: 12829155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy for Non-Small Cell Lung Cancer Induces DNA Damage Response in Both Irradiated and Out-of-field Normal Tissues.
    Siva S; Lobachevsky P; MacManus MP; Kron T; Möller A; Lobb RJ; Ventura J; Best N; Smith J; Ball D; Martin OA
    Clin Cancer Res; 2016 Oct; 22(19):4817-4826. PubMed ID: 27259562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the controlling effect of Shenqi Fuzheng injection on plasma cytokine network in patients with thoracic tumor undergoing radiotherapy].
    Liu L; Ding Q; Dai XF
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Dec; 27(12):1082-5. PubMed ID: 18198640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.